<DOC>
	<DOCNO>NCT02535676</DOCNO>
	<brief_summary>The aim study evaluate therapeutic efficacy tDCS ( transcranial direct current stimulation ) treatment negative symptom patient schizophrenia . The propose design clinical trial , randomize , double-blind , placebo-controlled study . Participants receive ten session active sham stimulation five consecutive day . 100 patient randomize two group ( active tDCS v sham tDCS ) assess intervention : 2 , 4 , 6 12 week . As objective , investigator expect see clinical improvement negative symptom scale PANSS ( Positive Negative Syndrome Scale ) , Calgary , Auditory verbal hallucination , SANS ( Skills Assessment Negative Symptoms ) , expect improvement computerized cognitive test . Another goal see improvement biological marker relate schizophrenia , plasma DNA store .</brief_summary>
	<brief_title>Schizophrenia TreAtment With electRic Transcranial Stimulation</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Diagnosis schizophrenia accord DSMIV criterion confirm SCID Minimum score 20 point sum negative PANSS Stable antipsychotic medication Unstable medical illness Uncontrolled pretreatment rTMS tDCS At least six month without ECT Benzodiazepines dose 10mg diazepam Electronic metal implant cephalic segment . Other mental disorder dependence substance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>transcranial stimulation</keyword>
</DOC>